Creative Planning - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
Creative Planning ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$207,0000.0%9,620
+11.5%
0.00%0.0%
Q3 2018$207,000
-27.9%
8,628
-63.2%
0.00%0.0%
Q4 2017$287,000
-20.9%
23,418
-11.7%
0.00%
-50.0%
Q3 2017$363,000
-9.7%
26,510
+0.5%
0.00%0.0%
Q2 2017$402,000
+52.3%
26,390
+84.0%
0.00%
+100.0%
Q1 2017$264,000
+116.4%
14,340
+9.3%
0.00%0.0%
Q4 2016$122,000
+144.0%
13,125
+118.8%
0.00%
Q3 2016$50,0006,0000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders